Search

Your search keyword '"Lebrun Frenay, C."' showing total 190 results

Search Constraints

Start Over You searched for: Author "Lebrun Frenay, C." Remove constraint Author: "Lebrun Frenay, C." Language english Remove constraint Language: english
190 results on '"Lebrun Frenay, C."'

Search Results

2. Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

3. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

4. Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

7. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

9. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions

12. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

16. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study

17. Improving the decision to switch from first to second-line therapy in MS: a dynamic scoring system

21. Mult Scler Relat Disord

22. A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

26. Sodium intake and multiple sclerosis activity and progression in BENEFIT

27. Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

29. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

30. Prior suggestive symptoms in third of patients consulting for a 'first' demyelinating event

31. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

32. THE PREVENTION OF POST-PARTUM RELAPSES WITH PROGESTIN AND ESTRADIOL IN MULTIPLE SCLEROSIS (POPART'MUS) TRIAL: RATIONALE, OBJECTIVES AND STATE OF ADVANCEMENT

38. Determinants of therapeutic lag in multiple sclerosis

39. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

40. Natural history of multiple sclerosis with childhood onset.

42. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

43. Analysis of healthcare utilization before the diagnosis of radiologically isolated syndrome.

44. Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis.

45. Alexithymia in radiologically isolated syndrome.

46. French validation of the sexual complaints screener (SCS) for patients with multiple sclerosis.

47. Time to move past typical syndromes in the diagnosis of multiple sclerosis.

48. T2-fluid attenuated inversion recovery fat-suppressed mismatch in the identification and characterization of lesions related to radiologically isolated syndrome.

49. Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.

50. Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis.

Catalog

Books, media, physical & digital resources